ENDRA Life Sciences Inc.
NDRA
$6.46
$1.1922.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 32.50% | 25.25% | 38.93% | 9.20% | 8.36% |
| Total Depreciation and Amortization | -11.74% | -22.79% | -23.71% | -25.70% | -24.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.99% | -42.71% | -55.80% | 37.91% | 149.29% |
| Change in Net Operating Assets | 673.80% | 769.70% | -83.07% | 121.12% | 106.55% |
| Cash from Operations | 13.56% | 23.52% | 29.97% | 36.89% | 38.01% |
| Capital Expenditure | -8.09% | 100.00% | -8.13% | 24.45% | 24.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,824.28% | -40,376.19% | -23,472.66% | -64.76% | -64.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 282.44% | -33.55% | -37.39% | -70.88% | -75.81% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -156.54% | -100.00% |
| Cash from Financing | 784.38% | -21.84% | -26.59% | -87.84% | -90.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 181.26% | -283.66% | -723.63% | -380.08% | -390.40% |